Skip to main content
OFIX logo

OFIX · Orthofix Medical Inc. · Executive Compensation

Track OFIX — free
$6.80 -0.37 (-5.16%) At close · Nov 16 Play latest call Q3 2026 earnings call transcript
Market Cap
$277.17M
Shares
40.76M
Volume · Nov 16 604.2K Avg daily vol (3M) 467.39K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Vickie Capps Appointed 2025-03-12
John B. Henneman, III Appointed 2024-06-20
Jason M. Hannon Appointed 2024-06-20
Charles R. Kummeth Appointed 2024-06-20
Wayne Burris Appointed 2024-06-20
Michael M. Finegan Appointed 2024-06-20
Julie Andrews Appointed 2024-01-17
Julie Andrews Appointed 2024-01-17
Julie Andrews Appointed 2024-01-09
Massimo Calafiore Appointed 2024-01-09
Massimo Calafiore Appointed 2024-01-09
Charles Kummeth Appointed 2023-12-15
Michael Finegan Appointed 2023-12-15
Alan Bazaar Appointed 2023-12-15
Charles R. Kummeth Appointed 2023-12-15
Michael M. Finegan Appointed 2023-12-15
Alan L. Bazaar Appointed 2023-12-15
Massimo Calafiore Appointed 2023-12-01
Keith C. Valentine Resigned 2023-10-05
Geoffrey C. Gillespie Appointed 2023-09-14
Puja Leekha Appointed 2023-09-14
Patrick Keran
“These matters are unrelated to and do not impact the Company’s strategy, results of operations or previously filed financial statements.”
Terminated 2023-09-14
Catherine M. Burzik Appointed 2023-09-14
John Bostjancic
“These matters are unrelated to and do not impact the Company’s strategy, results of operations or previously filed financial statements.”
Terminated 2023-09-14
Keith Valentine
“These matters are unrelated to and do not impact the Company’s strategy, results of operations or previously filed financial statements.”
Terminated 2023-09-14

Leadership

Key facts CIK 884624 CUSIP 68752M108 13F (30d) 125 filings 110 filers Visit website Investor relations